Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | PFE | BACK |
|---|---|---|---|
| Return | |||
| Last Price | — | 28.52 | 0.00 |
| Daily Change | — | − 1.01% | 0.00% |
| Period ReturnPast 6 Months | — | + 5.22% | 0.00% |
| Valuation | |||
| Market Cap | $4.50 B | $163 B | $1.89 K |
| P/E Ratio | — | — | — |
| Dividend Yield | — | — | — |
| Net MarginTrailing 12M | — | — | 23,232.4% |
| Risk | |||
| Beta | — | — | -1.12 |
| 52-Week Range | — | — | 0.00 — $0.21 |
| Company | |||
| Sector | — | Health Care | — |
| Industry | Biotechnology | Pharmaceuticals | Biotechnology |
Company
- AKROBiotechnology
- PFEHealth Care · Pharmaceuticals
- BACKBiotechnology
Metrics could not be loaded for AKRO, PFE: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 21:03
To Understand This